Clinico-Pathological Factors Determining Recurrence of Phyllodes Tumors of the Breast: The 25-Year Experience at a Tertiary Cancer Centre
Authors:
- Baijaeek SainBSBaijaeek Sain
- Arnab GuptaAGArnab Gupta
- Aruni GhoseAGAruni Ghose
- Sudip HalderSHSudip Halder
- Vishal MukherjeeVMVishal Mukherjee
- Samir BhattacharyaSBSamir Bhattacharya
- Radha Raman MondalRMRadha Raman Mondal
- Aditya Narayan SenASAditya Narayan Sen
- Bijan SahaBSBijan Saha
- Shravasti RoySRShravasti Roy
- Stergios BoussiosStergios Boussios
Open Access
- 21 May 2023
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (5) , 866
Abstract
Background: Phyllodes tumors (PTs) of the breast are rare fibroepithelial tumors that are generally more prone to recurrence. Aims and objectives: This study aimed to assess the clinicopathological features, diagnostic modalities, and therapeutic interventions, along with their respective outcomes, to identify the factors associated with a recurrence of PTs of the breast. Methodology: A retrospective cohort and observational study was conducted, which entailed analyzing the clinicopathological data of patients who were previously diagnosed or presented with PTs of the breast between 1996 and 2021. Data included the total number of patients diagnosed with PTs of the breast and their ages, tumor grade on initial biopsy, tumor location (left or right breast), tumor size, therapeutic interventions carried out (including surgery—either mastectomy or lumpectomy—and adjuvant radiotherapy), final tumor grade, recurrence status, type of recurrence, and time to recurrence. Results: We analyzed data on a total of 87 patients who were pathologically proven to have PTs, and 46 patients (52.87%) were found to have recurrences. All patients were female, with a mean age at diagnosis of 39 years (range 15–70). Patients aged 40 years, with a rate of recurrence of 45.65% (n = 21/46). A total of 55.4% of patients presented with primary PTs and 44.6% had recurrent PTs at presentation. The average time to local recurrence (LR) from the completion of treatment was 13.8 months, whereas for systemic recurrence (SR), it was 15.29 months. Surgery (mastectomy/lumpectomy) was the major determinant for local recurrence (p < 0.05). Conclusion: Patients who received adjuvant radiotherapy (RT) had a minimal recurrence of PTs. Patients who were found to have a malignant biopsy on initial diagnosis (triple assessment) had a higher incidence of PTs and were more prone to SR than LR. Surgery was a determining factor in the increased rate of LR, with lumpectomy associated with a higher incidence of LR than mastectomy.Keywords
This publication has 31 references indexed in Scilit:
- Phyllodes Tumor of Breast: A Review ArticleISRN Surgery, 2013
- The clinical features and prognosis of phyllodes tumors: a single institution experience in TaiwanInternational Journal of Clinical Oncology, 2012
- Low local recurrence rates in young Asian patients with phyllodes tumours: less is moreAnz Journal of Surgery, 2012
- The sensitivity of needle core biopsy in combination with other investigations for the diagnosis of phyllodes tumours of the breastInternational Journal of Surgery, 2012
- Imaging findings in phyllodes tumors of the breastEuropean Journal of Radiology, 2012
- Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical marginsJournal of Clinical Pathology, 2011
- Differential diagnosis between fibroadenoma, giant fibroadenoma and phyllodes tumour: sonographic features and core needle biopsyLa radiologia medica, 2011
- National Surgical Patterns of Care for Primary Surgery and Axillary Staging of Phyllodes TumorsThe Breast Journal, 2009
- Malignant Phyllodes Tumor of the Breast: Local Control Rates With Surgery AloneInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Clinicopathologic Features and Long-Term Outcomes of 293 Phyllodes Tumors of the BreastAnnals of Surgical Oncology, 2007